Home › NDC Lookup › RxCUI directory › RxCUI 240906

5 ML pegaspargase 750 UNT/ML Injection — RxCUI 240906

RxNorm drug concept · Semantic clinical drug
RxCUI 240906 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI240906
Official name5 ML pegaspargase 750 UNT/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspegaspargase 3750 UNT per 5 ML Injection; pegaspargase 3750 UNT in 5 ML Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pegaspargase Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Oncaspar targets acute lymphoblastic leukemia — a cancer where the bone marrow makes too many abnormal white blood cells. It works by cutting off a key nutrient (asparagine) that l...
  • What exactly is Oncaspar treating, and why is it part of my chemotherapy?
  • Oncaspar can sometimes trigger serious allergic reactions — including anaphylaxis, a sudden whole-body reaction that can affect your breathing and blood pressure. That hour of obse...
  • Why do I have to stay at the clinic for an hour after each dose?
📖 Read our full Pegaspargase Injection guide →

🕸️ Concept Web — How 5 ML pegaspargase 750 UNT/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 5 ML pegaspargase 750 UNT/ML Injection RxCUI 240906

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Pegaspargase 34132
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Oncaspar 224911
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pegaspargase Injection 1728058
    • Pegaspargase Injectable Product 1161379
    • Pegaspargase Injection [Oncaspar] 1728060
    • Oncaspar Injectable Product 1181715
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pegaspargase 750 UNT/ML SCDC · 316450
  • Pegaspargase Injection SCDF · 1728058
  • Pegaspargase Injectable Product SCDG · 1161379

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 240906 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72694-0954-01 1 VIAL, SINGLE-USE in 1 CARTON (72694-954-01) / 5 mL in 1 V... ONCASPAR Servier Pharmaceuticals LLC 2020-01-02
Observed labelers: Servier Pharmaceuticals LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9266 Pegaspargase injection 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.